• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Heather Raglin

Latest:

Antimicrobial Peptides Show Promise in Management of Atopic Dermatitis

Natural and synthetic antimicrobial peptides can penetrate deeper skin layers.



R. Annetta Zhou, PhD

Latest:

Association Between Use of Clinician Performance Information and Patient Experience

High patient experience scores were associated with the collection and use of any clinician performance information, especially with whether the practice shared this information internally to compare.


Travis Brewer

Latest:

Balancing Cost and Quality in Oncology: A Value-Based Care Perspective

Travis Brewer, vice president of payer and public health strategy/relations at Texas Oncology, shared that value-based oncology care can achieve both cost efficiency and high-quality outcomes through integrated multidisciplinary teams, flexible payment models, and targeted treatment approaches.


Roger D. Feldman, PhD

Latest:

Use of Voluntary Alignment in the Next Generation ACO Model

Use of voluntary alignment attribution by Next Generation Accountable Care Organization (ACO) participants was limited. The authors highlight the reasons and describe organizational use cases via a mixed-methods approach.


Andréa Caballero, MPA

Latest:

The Health Care Price Crisis Needs Policy Solutions

This commentary, part of the Price Crisis campaign, calls for state and federal policy interventions that are needed to rebalance the market to enhance competition and provide value in health care.


Jody Agena, PharmD, MBA

Latest:

Understanding the Role of the Pharmacist in Clinical Oncology: Jody Agena, PharmD, MBA

Jody Agena, PharmD, MBA, director of pharmacy operations, Virginia Cancer Specialists, discusses the various responsibilities of the pharmacist within community oncology settings.


Aina Katsikas, PhD

Latest:

Evaluating Racial Concordance in a Telephonic Care Management Program Among Black Patients

The race of a telephonic care manager did not impact closure rates for gaps in care among Black Medicare Advantage beneficiaries.


Danielle L. Tepper, MHA

Latest:

Hands Down, COVID-19 Will Change Medical Practice

Coronavirus disease 2019 (COVID-19) has challenged us to incorporate technology into engaging, interacting with, and caring for patients, using televisits and video conferencing in ways that have previously been resisted or derided.


Ratna Kiran Bhavaraju-Sanka, MD

Latest:

Advancing Myasthenia Gravis Treatment Access and Management

Experts discuss personalized myasthenia gravis treatment, emphasizing patient education and engagement for optimal care and advocacy in managing this variable disease.


Ubong Silas, MSc

Latest:

Clinical Outcomes in Heart Failure Monitoring: A Pooled Rates Analysis

This systematic literature review and pooled rates analysis investigated the standard of care for patients with heart failure in the US post hospital discharge.


Kyle Kitchen, PharmD, MBA

Latest:

The Future of IV and Subcutaneous Therapies in Oncology

Panelists discuss how subcutaneous (SubQ) and intravenous (IV) oncology therapies will continue to coexist, with patient-specific factors guiding delivery method choices, while ongoing innovation and collaboration drive the growing integration of SubQ formulations as a convenient and adaptable option in cancer care.


Patrick Gregory, PharmD

Latest:

Improving Glycemic Control in Diabetes Through Virtual Interdisciplinary Rounds

Patients with diabetes whose providers received advice from remote, virtual interdisciplinary rounds had a greater 1-year reduction in hemoglobin A1c than comparable patients.


Stephanie L. Graff, MD

Latest:

Research Landscape: Endocrine Therapies for ER+/HER2- Metastatic Breast Cancer

Stephanie Graff, MD, concludes the discussion with thoughts on endocrine therapies in development for patients with ER+/HER2- metastatic breast cancer.


Jennifer St. Clair Russell, PhD, MSEd, MCHES

Latest:

Health Care Costs Associated With Unrecognized Progression to Late-Stage Kidney Disease

Unrecognized disease progression is associated with higher health care costs both for patients with end-stage kidney disease and late-stage (stages G4-G5) chronic kidney disease.


Kristine Gonnella, MPH

Latest:

A Multistakeholder Effort in Pennsylvania to Improve the Accuracy of Reporting Fatal Drug Overdoses

The authors describe a novel training program for death certifiers in Pennsylvania, which has been designed to specifically focus on some of the main challenges in the death certification process and resulted in a useful model that can potentially be adopted by other states or municipalities.


David Annand, MD

Latest:

Value-Based Care Through Postacute Home Health Under CMS PACT Regulations

Among a patient population defined by CMS postacute care transfer regulations, home health vs no postacute care was associated with reduced 30-day readmissions and costs.


Nada M. Farhat, PharmD, BCPS, BCACP

Latest:

Pharmacist Hypertension Management Using an Electronic Health Record–Based Approach

The authors studied the impact of a pharmacist intervention on blood pressure control compared with usual care.


Ofer Kobo, MD

Latest:

Predicting Mortality Risk Using the PREVENT Equation Across Diverse Racial Groups

This study validates the Predicting Risk of CVD Events (PREVENT) score across diverse racial and ethnic populations, highlighting its effectiveness in predicting cardiovascular risk and mortality, regardless of race or ethnicity.


Megan Coylewright, MD, MPH

Latest:

Coverage With Evidence Development: Where Are We Now?

Review of CMS’ coverage with evidence development program exposes a need to improve program transparency and clarify requirements and timetables for reporting to improve access to novel therapies.



Rachael Matulis, MPH

Latest:

Value-Based Payment, the Safety Net, and Rethinking Risk

Safety-net providers can benefit from demonstrations of condition-specific and defined-scope-of-practice alternative payment models that account for the nonfinancial as well as financial risks that providers face.


P. David Charles, MD

Latest:

Utilization Management and Physician Burnout

This survey assesses physician experiences with utilization management and burnout and investigates whether there is a link between them.


Michael Ryan, MS

Latest:

The Unintended Consequences of Medicare’s Wage Index Adjustment on Device-Intensive Hospital Procedures

The authors found an association between Medicare’s wage index adjustment and the differential use of labor-intensive surgical procedures and medical device–intensive minimally invasive clinical procedures across the United States.


John Brandsema, MD

Latest:

Final Panel Thoughts on the Management of SMA

Panelists discuss how spinal muscular atrophy (SMA) treatment will evolve over the next 5 years, likely incorporating improved gene therapy delivery systems, combination therapies, and rehabilitation models, while maintaining individualized approaches for each patient.


Christopher Crow, MD, MBA

Latest:

Contributor: 3 Ways Technology Empowers PCPs and Patients to Transform the Health Care Experience and Improve Outcomes

Tech-driven connectivity and collaboration tools empower primary care providers (PCPs) to shepherd patient care, while simultaneously empowering patients to make more informed and strategic decisions about their own health and care journey.


Jo Varshney, PhD, DVM

Latest:

How AI Is Transforming Drug Development: Jo Varshney, PhD, DVM

Jo Varshney, PhD, DVM, discusses how artificial intelligence–powered simulations speed drug approvals and reduce clinical trial risk.


Boon Peng Ng, PhD

Latest:

Inability to Access Health Care Due to COVID-19 Among Medicare Beneficiaries

Up to one-fifth of Medicare beneficiaries were unable to access health care due to the COVID-19 pandemic in 2020.


Jonathan Thompson, MD, MS

Latest:

Addressing Financial and Socioeconomic Barriers to Precision NSCLC Care: Jonathan Thompson, MD, MS

Jonathan Thompson, MD, MS, explains how financial, insurance, and socioeconomic barriers limit equitable access to biomarker testing and advanced therapies, underscoring the need for provider advocacy and systemic support.


Jawad Haider Butt, MD, PhD

Latest:

High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment

Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based treatment strategies.

© 2025 MJH Life Sciences
AJMC®
All rights reserved.